BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 28341023)

  • 21. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Throat Carriage Rate and Antimicrobial Resistance of
    Delpech G; Sparo M; Baldaccini B; Pourcel G; Lissarrague S; García Allende L
    J Prev Med Public Health; 2017 Mar; 50(2):127-132. PubMed ID: 28372355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections.
    Brandt CM; Schweizer KG; Holland R; Lütticken R; Freyaldenhoven BS
    Int J Med Microbiol; 2005 Dec; 295(8):539-46. PubMed ID: 16325550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in Streptococcus pyogenes causing invasive disease in Portugal: evidence for superantigen gene loss and acquisition.
    Friães A; Lopes JP; Melo-Cristino J; Ramirez M;
    Int J Med Microbiol; 2013 Dec; 303(8):505-13. PubMed ID: 23932912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Pharyngitis Associated With Streptococcus dysgalactiae Subspecies equisimilis in Children.
    Kakuya F; Kinebuchi T; Okubo H; Matsuo K; Kuroda M; Fujiyasu H
    Pediatr Infect Dis J; 2018 Jun; 37(6):537-542. PubMed ID: 29227465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of group G Streptococcus dysgalactiae subsp. equisimilis recovered from patients and healthy people in China.
    Yin J; Yu S; Liu X; Li Y; Gao W; Zhou L; Ji L; Shen X; Yang Y
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):41-6. PubMed ID: 22078907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States.
    Ahmad Y; Gertz RE; Li Z; Sakota V; Broyles LN; Van Beneden C; Facklam R; Shewmaker PL; Reingold A; Farley MM; Beall BW
    J Clin Microbiol; 2009 Jul; 47(7):2046-54. PubMed ID: 19386831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Complement-Mediated Cell Lysis-like Gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis Isolates From Japan (2014-2016).
    Takahashi T; Fujita T; Shibayama A; Tsuyuki Y; Yoshida H
    Ann Lab Med; 2017 Jul; 37(4):297-304. PubMed ID: 28445008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.
    Ikebe T; Okuno R; Sasaki M; Kanda Y; Otsuka H; Kawahara R; Ohya H; Suzuki M; Uchida K; Nihonmatsu H; Ohnishi M;
    J Infect Chemother; 2018 Feb; 24(2):117-122. PubMed ID: 29107650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
    Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
    J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group C Streptococcus dysgalactiae subsp. equisimilis in south-east Brazil: genetic diversity, resistance profile and the first report of human and equine isolates belonging to the same multilocus sequence typing lineage.
    Silva LG; Genteluci GL; Corrêa de Mattos M; Glatthardt T; Sá Figueiredo AM; Ferreira-Carvalho BT
    J Med Microbiol; 2015 May; 64(Pt 5):551-558. PubMed ID: 25752850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis & of group G S. anginosus group at a tertiary care centre.
    Behera B; Mathur P; Bhardwaj N; Jain N; Misra MC; Kapil A; Singh S
    Indian J Med Res; 2014 Mar; 139(3):438-45. PubMed ID: 24820839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergence of a Streptococcus dysgalactiae subspecies equisimilis stG62647-lineage associated with severe clinical manifestations.
    Oppegaard O; Mylvaganam H; Skrede S; Lindemann PC; Kittang BR
    Sci Rep; 2017 Aug; 7(1):7589. PubMed ID: 28790435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.
    Rantala S
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1303-10. PubMed ID: 24682845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Streptococcal pyrogenic exotoxin G gene in blood and pharyngeal isolates of Streptococcus dysgalactiae subspecies equisimilis has a limited role in pathogenesis.
    Korem M; Hidalgo-Grass C; Michael-Gayego A; Nir-Paz R; Salameh S; Moses AE
    J Microbiol Immunol Infect; 2014 Aug; 47(4):292-6. PubMed ID: 23380619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes.
    Cascone C; Santagati M; Noviello S; Iannelli F; Esposito S; Pozzi G; Stefani S
    Microb Drug Resist; 2002; 8(2):129-32. PubMed ID: 12118517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular subtyping and antimicrobial susceptibility of
    Oh SI; Kim JW; Kim J; So B; Kim B; Kim HY
    J Vet Sci; 2020 Jul; 21(4):e57. PubMed ID: 32735095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal diversity among erythromycin-resistant beta-haemolytic Streptococcus isolates in La Rioja, Spain.
    Portillo A; Gastañares MJ; Ruiz-Larrea F; Torres C
    J Antimicrob Chemother; 2003 Sep; 52(3):485-8. PubMed ID: 12888595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
    Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
    J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.